Simple blood test for colon cancer on the horizon?
NCT ID NCT07153458
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study is looking for new substances in the blood that could signal colorectal cancer (CRC) or pre-cancerous growths. Researchers will compare blood samples from 60 people: those with CRC, those with a pre-cancerous polyp, and healthy individuals. The goal is to create a scoring system that could predict or diagnose CRC without invasive procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to detect colorectal cancer earlier or predict its development.
- What could go wrong
- This is a small, early observational study, not a treatment trial. The biomarkers identified may not prove accurate enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOMA COLON are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biobank Core Facility
RECRUITINGCastellana Grotte, 70013, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dental floss loop make polyp removal faster?
- Can a four-pronged attack shrink liver tumors enough for surgery?
- Can a Two-Pronged antibody boost chemo against Hard-to-Treat colorectal cancer?
- New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
- Real-World data on colorectal cancer: what happens to patients over time?
- Engineered immune cells take on Hard-to-Treat colorectal cancer